Opportunity Information: Apply for RFA CA 19 003

The Pediatric Immunotherapy Discovery and Development Network (PI-DDN) funding opportunity (RFA-CA-19-003) is a National Institutes of Health cooperative agreement designed to build a coordinated, multi-investigator network of research centers focused on pediatric cancer immunotherapy. It sits under the Department of Health and Human Services and is tied to the Beau Biden Cancer Moonshot Initiative, which was created to speed up progress against cancer by pushing promising science toward real-world impact more quickly. The core aim here is translational science for children and adolescents with cancer: not simply studying immune-oncology in the abstract, but deliberately identifying, prioritizing, and advancing immunotherapy ideas that can be moved toward clinical application. Even though the mechanism is oriented toward translation, the FOA explicitly indicates "Clinical Trial Not Allowed," meaning the supported work is meant to enable and de-risk future pediatric immunotherapy trials rather than directly run them under this award.

This FOA responds directly to a scientific priority identified by the Cancer Moonshot Blue Ribbon Panel, specifically Recommendation B calling for a pediatric immunotherapy translational science network. In practical terms, NIH is seeking to fund PI-DDN Centers that operate as hubs of collaborating investigators, bringing together complementary expertise to solve key bottlenecks in pediatric immunotherapy. The network concept emphasizes team-based, coordinated progress rather than isolated projects. The centers are expected to work on discovering new immune targets relevant to pediatric tumors, developing new therapeutic approaches tailored for pediatric cancers, and clarifying why many childhood tumors evade immune attack in the first place. The opportunity highlights examples of development directions such as cancer vaccines, cellular therapies, and rational combinations of immunotherapy agents, reflecting an intent to support multiple modalities as long as they are focused on pediatric needs and are moving along a pipeline toward eventual clinical readiness.

A major theme is understanding and overcoming pediatric tumor immune evasion. Pediatric cancers often differ from adult cancers in their mutation burden, tumor microenvironment features, and immune interactions, which can affect how well adult-developed immunotherapies translate to children. By emphasizing mechanisms of immune escape, the FOA signals that strong applications will likely connect target discovery and therapy design to underlying biology, such as tumor antigenicity, immune suppression in the microenvironment, antigen presentation issues, or other barriers that limit immune recognition and killing. The expected output is not just publications, but actionable translational deliverables: validated targets, preclinical evidence packages, optimized platforms or constructs, and a clearer rationale for which immunotherapy strategies are most likely to succeed in pediatric settings.

The funding instrument is a U54 cooperative agreement, which typically means NIH expects substantial programmatic involvement and active coordination with awardees. In a cooperative agreement, the agency often plays a hands-on role in shaping network activities, harmonizing goals across centers, and encouraging data sharing and collaboration so that the entire network moves faster than any one group could on its own. The activity category is health (CFDA 93.353), and the opportunity was categorized as discretionary funding.

Eligibility is broad and includes many types of organizations: state, county, and local governments; public and private institutions of higher education; tribal governments and tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities as described in the additional eligibility text for the announcement. This wide eligibility suggests NIH was open to a range of institutional models, including academic medical centers, research institutes, and potentially industry or mixed partnerships, as long as the applicant could credibly function as a networked center with the necessary expertise and infrastructure to advance pediatric immunotherapy translation.

Key administrative details in the source data include a creation date of August 13, 2018 and an original closing date of December 17, 2018. The award ceiling listed is $1,600,000, and the expected number of awards is 1 based on the provided fields, indicating a competitive opportunity with limited slots and an emphasis on building a flagship or highly coordinated center-based effort. Overall, the PI-DDN FOA is best understood as an NIH-backed, Cancer Moonshot-driven attempt to create a structured translational pipeline for pediatric immunotherapy: find promising targets, engineer and refine therapeutic approaches suited to children, and generate the biological and preclinical foundation needed to move the most compelling strategies into later-stage clinical testing under separate trial-allowing mechanisms.

  • The Department of Health and Human Services, National Institutes of Health in the health sector is offering a public funding opportunity titled "Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.353.
  • This funding opportunity was created on Aug 13, 2018.
  • Applicants must submit their applications by Dec 17, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,600,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for RFA CA 19 003

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: Department of Health and Human Services, National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Trail preservation

Previous opportunity: Fort Huachuca Environmental Training

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 19 003

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 19 003) also looked into and applied for these:

Funding Opportunity
Strengthening the Public Health System in the U.S.-Affiliated Pacific Islands Apply for CDC RFA OT16 16010301SUPP18

Funding Number: CDC RFA OT16 16010301SUPP18
Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS
Category: Health
Funding Amount: $1,000,000
Strategic Information Support Across Countries under the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria and under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1951

Funding Number: CDC RFA GH19 1951
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities, Cancer Activities Apply for HHS 2018 IHS EPI 0001

Funding Number: HHS 2018 IHS EPI 0001
Agency: Department of Health and Human Services, Indian Health Service
Category: Health
Funding Amount: $220,000
Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities, Rocky Mountain Spotted Fever Apply for HHS 2018 IHS EPI 0002

Funding Number: HHS 2018 IHS EPI 0002
Agency: Department of Health and Human Services, Indian Health Service
Category: Health
Funding Amount: $300,000
Strengthen Capacity of South African Government's Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care for Unstable HIV and TB/HIV Patients in the Republic of South Africa under PEPFAR Apply for CDC RFA GH19 1923

Funding Number: CDC RFA GH19 1923
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $5,000,000
Supporting Counties and Other Indigenous Health Management Institutions to Bridge Skill Gaps Among Health Care Workforce Necessary for HIV Epidemic Control in Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1929

Funding Number: CDC RFA GH19 1929
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $689,776
Scaling High Quality Laboratory Services for HIV Diagnosis, Care, Treatment and Monitoring in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1938

Funding Number: CDC RFA GH19 1938
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $5,000,000
Enhance Population Access to Comprehensive HIV/AIDS Services in order to Achieve HIV/AIDS Epidemic Control in the Democratic Republic of Congo (DRC), Specifically in Haut - Katanga under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1933

Funding Number: CDC RFA GH19 1933
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $3,500,000
Rural Opioids Technical Assistance Grants Apply for TI 18 022

Funding Number: TI 18 022
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis
Category: Health
Funding Amount: $8,250,000
Packaging and Spreading Proven Pediatric Weight Management Interventions for Use by Low-Income Families Apply for RFA DP 19 002

Funding Number: RFA DP 19 002
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $750,000
Building and Improving Laboratory Capacity and Quality in the Democratic Republic of Congo (DRC) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1932

Funding Number: CDC RFA GH19 1932
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,500,000
Lost Wages Support for Living Organ Donors Demonstration Project Apply for HRSA 19 069

Funding Number: HRSA 19 069
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Rural Health Network Development Planning Program Apply for HRSA 19 025

Funding Number: HRSA 19 025
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Rape Prevention and Education: Using The Best Available Evidence for Sexual Violence Prevention Apply for CDC RFA CE19 1902

Funding Number: CDC RFA CE19 1902
Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC
Category: Health
Funding Amount: $3,500,000
Improving Laboratory Capacity and Quality in the Scale-up of HIV Diagnosis, Care, Treatment, and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1910

Funding Number: CDC RFA GH19 1910
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
Consolidating Efforts Towards HIV and TB Epidemic Control in the Kenya Prisons Service (KPS) through Scale Up of High Quality HIV and TB Services, Capacity Strengthening, and Health System Strengthening under PEPFAR Apply for CDC RFA GH19 1928

Funding Number: CDC RFA GH19 1928
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $2,500,000
Improving Quality of Care and Health Impact through Innovative Electronic Medical System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1912

Funding Number: CDC RFA GH19 1912
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
Optimizing Performance by Improving Quality (OPIQ) in HIV and HIV/TB Programs in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1921

Funding Number: CDC RFA GH19 1921
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $5,000,000
Enhance the National Department of Health's Coordination and Leadership on HIV and TB Programs in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1913

Funding Number: CDC RFA GH19 1913
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $90,000,000
Strengthening Strategic Information, Program Implementation and Capacity Building in order to Reduce Morbidity and Mortality in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1911

Funding Number: CDC RFA GH19 1911
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: $2,500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: